Abstract
BACKGROUND: Underlying immunological mechanisms in children with moderate-to-severe asthma are complex and unclear. We aimed to investigate the association between blood inflammatory parameters and asthma burden in children with moderate-to-severe asthma.
METHODS: Blood inflammatory parameters (eosinophil and neutrophil counts and inflammatory mediators using multiplex immunoassay technology) were measured in children (6-17 years) with moderate-to-severe asthma from the SysPharmPediA cohort across four European countries. Based upon low/high blood eosinophil (LBE/HBE) counts of </≥0.3×10 9·L -1, respectively and low/high blood neutrophil (LBN/HBN) counts of </≥4×10 9·L -1, respectively, mixed (HBE-HBN), eosinophilic (HBE-LBN), neutrophilic (LBE-HBN) and paucigranulocytic (LBE-LBN) phenotypes were defined. Inflammatory mediator profiles and burden of disease (asthma control status, exacerbations and school days missed in the past year) were compared between phenotypes using adjusted logistic regression models.
RESULTS: Among 126 included children (41% girls and mean (sd) age of 11.94 (2.76)), 22%, 44%, 11% and 23% were classified as mixed, eosinophilic, neutrophilic and paucigranulocytic phenotypes, respectively. Neutrophilic children had the lowest lung function (forced expiratory volume in 1 s % predicted pre-salbutamol) compared with other groups. Children with mixed asthma were most often uncontrolled and had the highest asthma-related school absence in the past year. Interleukin (IL)-6 and matrix metalloproteinase-9 levels were significantly higher in patients with mixed or neutrophilic asthma, whereas tissue inhibitor of metalloproteinase-2 was lower in patients with neutrophilic asthma compared with eosinophilic or paucigranulocytic asthma. IL-5 was increased in eosinophilic group compared with the neutrophilic and paucigranulocytic groups, irrespective of the chosen cut-off for eosinophilia.
CONCLUSION: Differences in asthma burden-related clinical expression and distinct blood inflammatory mediator profiles were found between phenotypes, highlighting implications for optimising personalised treatment and management strategies in children with moderate-to-severe asthma.
| Original language | English |
|---|---|
| Article number | 00222-2024 |
| Journal | ERJ Open Research |
| Volume | 10 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - Nov 2024 |
Bibliographical note
Copyright ©The authors 2024.Funding
The SysPharmPediA cohort is supported by ZonMW under project number 9 003 035 001; the Ministry of Education, Science, and Sport of the Republic of Slovenia with contract number C330\u201316\u2013500 106; the German Ministry of Education and Research with project number FKZ 031L0088; Instituto de Salud Carlos III through Strategic Action for Health Research; and European Community within the Active and Assisted Living Program framework with award numbers AC15/00015 and AC15/00058 under the frame of the ERACoSysMed JTC-1 call. Funding information for this article has been deposited with the Crossref Funder Registry.
| Funders | Funder number |
|---|---|
| Instituto de Salud Carlos III | |
| European Commission | AC15/00015, AC15/00058 |
| ZonMw | 9 003 035 001 |
| Ministry of Education, Science, and Sport of the Republic of Slovenia | C330–16–500 106 |
| Bundesministerium für Bildung und Forschung | FKZ 031L0088 |